Anticancer Agents (Record no. 8841)

MARC details
000 -LEADER
fixed length control field 02866nam a2200121Ia 4500
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 220615s9999||||xx |||||||||||||| ||und||
245 #0 - TITLE STATEMENT
Title Anticancer Agents
Remainder of title Design, Synthesis and Evaluation
546 ## - LANGUAGE NOTE
Language note English[eng]
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element benzofurans||chemical synthesis||cytotoxic properties||HeLa||MOLT-4||K562||anticancer||anti-neuroinflammation||coumarin||dihydroartemisinin||flavonoids||allene||E-stereoselective||regioselective||anti-cancer activity||cyanopyridone||substituted pyridine||pyridotriazine||pyrazolopyridine||thioxotriazopyridine||anticancer activity||HepG2||antitumor activity||computational docking||MDM2-p53 interaction||xanthones||yeast-based assays||estrone derivatives||hydrazine||N-substituted pyrazoline||anti-ovarian cancer||topoisomerase II inhibitor||kinase inhibitor||antiproliferative agent||urea||synthesis||antiproliferative activity||apoptosis||indoleamine 2,3-dioxygenase||inhibitor||anti-tumor||immune modulation||tryptophan metabolism||taxoids||βIII-tubulin||P-glycoprotein||drug resistance||thiopene||thienopyrimidinone||thiazolidinone||breast cancer||benzofuran–pyrazole||nanoparticles||cytotoxic activity||PARP-1 inhibition||3,6-dibromocarbazole||5-bromoindole||carbazole||actin||migration||Thienopyrimidine||Pyrazole||PI3Kα inhibitor||quinazolin-4(3H)-one||quinazolin-4(3H)-thione||Schiff base||antioxidant activity||DFT study||ortho-quinones||beta-lapachone||tanshione IIA||PI3Ks||PI3Kδ inhibitors||2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide||anticancer agents||protein–protein interactions||virtual screening||mimetics||drug discovery||bivalency||polyvalency||antitumor||cell cycle||ovarian cancer||P-MAPA||IL-12||TLR signaling||inflammation||chemoresistance||4-(pyridin-4-yloxy)benzamide||1,2,3-triazole||c-Met||natural product||anticancer agent||zampanolide||Talazoparib||PARP inhibitor||prodrug||o-nitro-benzyl||photoactivatable protecting groups||salinomycin||overcoming drug resistance||tumor specificity||synergy||5-fluorouracil||gemcitabine||amides/esters||colchicine analogs||thiocolchicine||colchiceine||antimitotic agents||hydrates||dihydropyranoindole||HDAC inhibitors||neuroblastoma||aromatase||MCF-7||NIH3T3||benzimidazole||triazolothiadiazine||docking||ADME||organosilicon compounds||SILA-409 (Alis-409)||SILA-421 (Alis-421)||multidrug resistance (MDR) reversal||ABCB1 (P-glycoprotein)||colon cancer||colchicine amide||colchicine sulfonamide||tubulin inhibitors||docking studies||crystal structure||PROTACs||protein degradation||IGF-1R||Src||protein kinase||phenylpyrazolopyrimidine||enzyme inhibition||molecular simulation||androgen receptor||prostate cancer||enzalutamide||apalutamide||darolutamide||triple-negative breast cancer||cytotoxicity||chrysin analogues||flavonoid||anticancer compounds
700 ## - ADDED ENTRY--PERSONAL NAME
Personal name Chen, Qiao-Hong
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://mdpi.com/books/pdfview/book/3445">https://mdpi.com/books/pdfview/book/3445</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type E-Books
Holdings
Withdrawn status Lost status Damaged status Not for loan Home library Current library Date acquired Total Checkouts Date last seen Price effective from Koha item type
        Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre Kerala University of Digital Sciences, Innovation and Technology Knowledge Centre 15/06/2022   15/06/2022 15/06/2022 E-Books